Atea Pharmaceuticals, Inc. - COM (AVIR)

Historical Portfolio Holders from Q4 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
57.9M
Holdings value Q3 2024
$194M
Value change Q3 2024
+$4.53M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
105
Number of buys Q3 2024
52
Number of sells Q3 2024
-39
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 57.9M $194M +$4.53M $3.35 105
2024 Q2 56.7M $188M +$7.27M $3.31 101
2024 Q1 54.3M $219M -$1.78M $4.04 111
2023 Q4 55.1M $168M -$1.58M $3.05 106
2023 Q3 56.8M $170M -$2.35M $3.00 116
2023 Q2 57M $213M +$971K $3.74 131
2023 Q1 56.8M $190M -$5.88M $3.35 128
2022 Q4 57.8M $278M -$5.13M $4.81 131
2022 Q3 57.4M $327M -$1.74M $5.69 114
2022 Q2 57.6M $409M +$19.5M $7.10 122
2022 Q1 54.9M $397M +$6.37M $7.22 122
2021 Q4 53.6M $479M -$368M $8.94 138
2021 Q3 56.8M $1.99B -$21.7M $35.06 141
2021 Q2 58.9M $1.27B +$161M $21.48 101
2021 Q1 47.4M $2.91B +$30.5M $61.75 79
2020 Q4 49.9M $2.07B +$1.82B $41.78 69